Q4 2023 Holdings
Filed 2024-02-14 | 7 holdings | $667.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rayzebio Inc | COM | 75525N107 | $320.7M | 5,158,162 | 48.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $144.4M | 9,699,925 | 21.6% |
| Pharvaris N V(PHVS) | COM | N69605108 | $138.0M | 4,919,504 | 20.7% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $33.4M | 1,035,396 | 5.0% |
| Acelyrin Inc | COM | 00445A100 | $28.7M | 3,852,470 | 4.3% |
| Elevation Oncology Inc | COM | 28623U101 | $1.6M | 2,914,255 | 0.2% |
| Impel Pharmaceuticals Inc | COM | 45258K109 | $340.8K | 2,759,791 | 0.1% |